Ovid Therapeutics Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Citadel | multi-strat | 1.32M | $2.93M | 0.00% | Trimmed-62.8% | 2026-03-31 |
| TwoSigma | quant | 1.26M | $2.79M | 0.00% | Added+109.9% | 2026-03-31 |
| RenTech | quant | 1.10M | $2.45M | 0.00% | Trimmed-25.6% | 2026-03-31 |
| StateStreet | passive | 520.3K | $1.16M | 0.00% | Added+88.1% | 2026-03-31 |
| FidelityFMR | fundamental | 42.1K | $93.55K | 0.00% | Trimmed-4.2% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.10 | — | — |
| 2026-05-12 | -0.11 | -0.12 | -13.21% |
| 2026-03-18 | -0.10 | 0.06 | +161.22% |
| 2025-11-12 | -0.15 | -0.17 | -14.86% |
| 2025-08-13 | -0.15 | -0.06 | +59.32% |
| 2025-05-13 | -0.13 | -0.14 | -7.69% |
| 2025-03-11 | -0.17 | -0.13 | +22.19% |
| 2024-11-12 | -0.23 | -0.20 | +11.89% |
| 2024-08-13 | -0.24 | 0.12 | +150.12% |
| 2024-05-14 | -0.23 | -0.17 | +26.64% |
| 2024-03-08 | 0.25 | -0.22 | -187.32% |
| 2023-11-03 | -0.19 | -0.16 | +14.22% |
| 2023-08-04 | -0.21 | -0.18 | +13.58% |
| 2023-05-05 | -0.17 | -0.19 | -10.99% |
| 2023-03-13 | -0.18 | -0.16 | +12.22% |
| 2022-11-08 | -0.21 | -0.17 | +19.05% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| OVID | -2.15% | +60.59% | +67.48% | +903.68% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -5.12% | +65.23% | +70.93% | +890.99% |